1 |
Marasco SF, Lukas G, McDonald M, et al. Review of ECMO (extra corporeal membrane oxygenation) support in critically ill adult patients [J]. Heart Lung Circ, 2008, 17 (Suppl 4): 41-47.
|
2 |
Vogel AM, Lew DF, Kao LS, et al. Defining risk for infectious complications on extracorporeal life support [J]. J Pediatr Surg, 2011, 46(12): 2260-2264.
|
3 |
Bizzarro MJ, Conrad SA, Kaufman DA, et al. Infections acquired during extracorporeal membrane oxygenation in neonates, children, and adults [J]. Pediatr Crit Care Med, 2011, 12(3): 277-281.
|
4 |
Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for nosocomial infections [J]. Am J Infect Control, 1988, 16(3): 128-140.
|
5 |
Tan VE, Moore WS, Chopra A, et al. Association of procalcitonin values and bacterial infections in pediatric patients receiving extracorporeal membrane oxygenation [J]. Perfusion, 2018, 33(4): 278-282.
|
6 |
Hsu MS, Chiu KM, Huang YT, et al. Risk factors for nosocomial infection during extracorporeal membrane oxygenation [J]. J Hosp Infect, 2009, 73(3): 210-216.
|
7 |
Burket JS, Bartlett RH, Vander HK, et al. Nosocomial infections in adult patients undergoing extracorporeal membrane oxygenation [J]. Clin Infect Dis, 1999, 28(4): 828-833.
|
8 |
Schmidt M, Brechot N, Hariri S, et al. Nosocomial infections in adult cardiogenic shock patients supported by venoarterial extracorporeal membrane oxygenation [J]. Clin Infect Dis, 2012, 55(12): 1633-1641.
|
9 |
Ayyɪldɪz P, Kasar T, Ozturk E, et al. The evaluation of nosocomial infections in pediatric patients with extracorporeal membrane oxygenation support [J]. Braz J Cardiovasc Surg, 2017, 32(6): 468-474.
|
10 |
Calderón Checa RM, Rojo Conejo P, González-Posada Flores AF, et al. Experience with infections in the use of extracorporeal membrane oxygenation [J]. Anales de Pediatría (Engl Ed), 2018, 89(2): 86-91.
|
11 |
Aubron C, Cheng AC, Pilcher D, et al. Infections acquired by adults who receive extracorporeal membrane oxygenation: risk factors and outcome [J]. Infect Control Hosp Epidemiol, 2013, 34(1): 24-30.
|
12 |
Sun HY, Ko WJ, Tsai PR, et al Infections occurring during extracorporeal membrane oxygenation use in adult patients [J]. J Thorac Cardiovasc Surg, 2010, 140(5): 1125-1132.
|
13 |
Kim GS, Lee KS, Park CK, et al. Nosocomial infection in adult patients undergoing veno-arterial extracorporeal membrane oxygenation [J]. J Korean Med Sci, 2017, 32(4): 593-598.
|
14 |
Winiszewski H, Boyadjian C, Besch G, et al. ECMO cannula-associated infections: interest of cannula swab and subcutaneous needle aspirate samples for prediction of cannula tip culture [J]. Intensive Care Med Exp, 2020, 8(1): 35.
|
15 |
Pieri M, Greco T, De Bonis M, et al. Diagnosis of infection in patients undergoing extracorporeal membrane oxygenation: a case-control study [J]. J Thorac Cardiovasc Surg, 2012, 143(6): 1411-1416.
|
16 |
Tanaka D, Pitcher HT, Cavarocchi NC, et al. Can procalcitonin differentiate infection from systemic inflammatory reaction in patients on extracorporeal membrane oxygenation? [J]. J Heart Lung Transplant, 2014, 33(11): 1186-1188.
|
17 |
Orszag P, Disque C, Keim S, et al. Monitoring of patients supported by extracorporeal membrane oxygenation for systemic infections by broad-range rRNA gene PCR amplification and sequence analysis [J]. J Clin Microbiol, 2013, 52(1): 307-311.
|
18 |
Biffi S, Di Bella S, Scaravilli V, et al. Infections during extracorporeal membrane oxygenation: epidemiology, risk factors, pathogenesis and prevention [J]. Int J Antimicrob Agents, 2017, 50(1): 9-16.
|
19 |
Meyer DM, Jessen ME, Eberhart RC. Neonatal extracorporeal membrane oxygenation complicated by sepsis. Extracorporeal Life Support Organization [J]. Ann Thorac Surg, 1995, 59(4): 975-980.
|
20 |
Douglass BH, Keenan AL, Purohit DM, et al. Bacterial and fungal infection in neonates undergoing venoarterial extracorporeal membrane oxygenation: an analysis of the registry data of the extracorporeal life support organization [J]. Artificial organs, 1996, 20(3): 202-208.
|
21 |
Cashen K, Reeder R, Dalton HJ, et al. Acquired infection during neonatal and pediatric extracorporeal membrane oxygenation [J]. Perfusion, 2018, 33(6): 472-482.
|
22 |
Tse-Chang A, Midodzi W, Joffe AR, et al. Infections in children receiving extracorporeal life support [J]. Infect Control Hosp Epidemiol, 2011, 32(2): 115-120.
|
23 |
Castagnola E, Gargiullo L, Loy A, et al. Epidemiology of infectious complications during extracorporeal membrane oxygenation in children: a single-center experience in 46 runs [J]. Pediatr Infect Dis J, 2018, 37(7): 624-626.
|
24 |
Quintana MT, Mazzeffi M, Galvagno SM, et al. A retrospective study of infection in patients requiring extracorporeal membrane oxygenation support [J]. Ann Thorac Surg, 2021, 112(4): 1168-1175.
|
25 |
O'Neill J, Schutze G, Heulitt MJ, et al. Nosocomial infections during extracorporeal membrane oxygenation [J]. Intensive Care Med, 2001, 27(8): 1247-1253.
|
26 |
Santiago-Lozano MJ, Barquín-Conde ML, Fuentes-Moreno L, et al. Infectious complications in paediatric patients treated with extracorporeal membrane oxygenation [J]. Enferm Infecc Microbiol Clin (Engl Ed), 2018, 36(9): 563-567.
|
27 |
Butler DF, Lee B, Molitor-Kirsch E, et al. Extracorporeal membrane oxygenation-associated bloodstream infections in children [J]. Pediatr Infect Dis J, 2017, 36(3): 346-347.
|
28 |
Kaczala GW, Paulus SC, Al-Dajani N, et al. Bloodstream infections in pediatric ECLS: usefulness of daily blood culture monitoring and predictive value of biological markers. The British Columbia experience [J]. Pediatr Surg Int, 2009, 25(2): 169-173.
|
29 |
Kutlesa M, Santini M, Krajinović V, et al. Nosocomial blood stream infections in patients treated with venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome [J]. Minerva Anestesiol, 2017, 83(5): 493-501.
|
30 |
Na SJ, Chung CR, Choi HJ, et al. Blood stream infection in patients on venovenous extracorporeal membrane oxygenation for respiratory failure [J]. Infect Control Hosp Epidemiol, 2018, 39(7): 871-874.
|
31 |
Wang JR, Huang JY, Hu W, et al. Bloodstream infections in patients undergoing extracorporeal membrane oxygenation [J]. Pak J Med Sci, 2020, 36(6): 1171-1176.
|
32 |
Menaker J, Galvagno S, Rabinowitz R, et al. Epidemiology of blood stream infection in adult extracorporeal membrane oxygenation patients: a cohort study [J]. Heart Lung, 2019, 48(3): 236-239.
|
33 |
Conrick-Martin I, O'Gorman J, Lenehan D, et al. Nosocomial infections in a cohort of extracorporeal life support patients [J]. Crit Care Resusc, 2012, 14(3): 198-201.
|
34 |
Grasselli G, Scaravilli V, Di Bella S, et al. Nosocomial infections during extracorporeal membrane oxygenation: incidence, etiology, and impact on patients' outcome [J]. Crit Care Med, 2017, 45(10): 1726-1733.
|
35 |
Bougle A, Bombled C, Margetis D, et al. Ventilator-associated pneumonia in patients assisted by veno-arterial extracorporeal membrane oxygenation support: epidemiology and risk factors of treatment failure [J]. PLoS One, 2018, 13(4): e0194976.
|
36 |
Allou N, Lo Pinto H, Persichini R, et al. Cannula-related infection in patients supported by peripheral ECMO: clinical and microbiological characteristics [J]. ASAIO J, 2019, 65(2): 180-186.
|
37 |
Schutze GE, Heulitt MJ. Infections during extracorporeal life support [J]. J Pediatr Surg 1995, 30(6): 809-812.
|
38 |
Pluim T, Halasa N, Phillips SE, et al. The morbidity and mortality of patients with fungal infections before and during extracorporeal membrane oxygenation support [J]. Pediatr Crit Care Med, 2012, 13(5): e288-293.
|
39 |
Cavayas YA, Yusuff H, Porter R. Fungal infections in adult patients on extracorporeal life support [J]. Crit Care, 2018, 22(1): 98.
|
40 |
Coffin SE, Bell LM, Manning M, et al. Nosocomial infections in neonates receiving extracorporeal membrane oxygenation [J]. Infect Control Hosp Epidemiol 1997, 18(2): 93-96.
|
41 |
Brown KL, Ridout DA, Shaw M, et al. Healthcare-associated infection in pediatric patients on extracorporeal life support: the role of multidisciplinary surveillance [J]. Pediatr Crit Care Med, 2006, 7(6): 546-550.
|
42 |
Silvetti S, Ranucci M, Pistuddi V, et al. Bloodstream infections during post-cardiotomy extracorporeal membrane oxygenation: Incidence, risk factors, and outcomes [J]. Int J Artif Organs, 2019, 42(6): 299-306.
|
43 |
Rodriguez-Goncer I, Thomas S, Foden P, et al. Invasive pulmonary aspergillosis is associated with adverse clinical outcomes in critically ill patients receiving veno-venous extracorporeal membrane oxygenation [J]. Eur J Clin Microbiol Infect Dis, 2018, 37(7): 1251-1257.
|
44 |
Gardner AH, Prodhan P, Stovall SH, et al. Fungal infections and antifungal prophylaxis in pediatric cardiac extracorporeal life support [J]. J Thorac Cardiovasc Surg, 2012, 143(3): 689-695.
|
45 |
Extracorporeal Life Support Organization (ELSO). ELSO Task Force on Infectious Disease on ECMO: diagnosis, treatment and prevention [EB/OL]. Ann Arbor, MI: ELSO. (2012) [2017-05-12]
URL
|
46 |
O'Horo JC, Cawcutt KA, De Moraes AG, et al. The evidence base for prophylactic antibiotics in patients receiving extracorporeal membrane oxygenation [J]. ASAIO J, 2016, 62(1): 6-10.
|
47 |
Corley A, Lye I, Lavana JD, et al. Nosocomial infection prevalence in patients undergoing extracorporeal membrane oxygenation (ECMO): protocol for a point prevalence study across Australia and New Zealand [J]. BMJ Open, 2019, 9(7): e029293.
|